Topic: Venture Capital

Fusion raises US $25 million for cancer targeting technology

Fusion Pharmaceuticals Inc, a spin out of the Centre for Probe Development and Commercialization (CPDC), has secured US$25 million in series ‘A’ financing to support and accelerate development of new next-generation therapeutics that precisely target cancer cells.

Microbion Corp received US$25 million in venture funding

Vancouver and Bozeman MT-based -based Microbion Corp has received US$25-million in venture capital to further develop its lead compound for the treatment of antibiotic-resistant infections. The funding is being provided by the Global Health Sciences Venture Fund, a US$500-million joint venture between Vancouver’s Quark Venture Inc and GF Securities, a Hong Kong-based investment bank. The…

Klipfolio raises $12M in series ‘B’ financing

Ottawa-based Klipfolio has received $12 million in series ‘B’ financing from an investment syndicate led by OMERS Ventures to further develop its cloud app for building and sharing real-time business dashboards on web browsers, TV monitors and mobile devices. Described as a pre-emptive insiders round, the financing is the largest the company has received to…